CRISPR Therapeutics AG (CRSP) Research & Development (2015 - 2026)
CRISPR Therapeutics AG's Research & Development was $67.15 million in Q2 2026, down 3.9% from $69.89 million a year earlier and down 2.1% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Research & Development (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, CRISPR Therapeutics AG's Research & Development was $278.15 million through Jun 30, 2026, down 6.1% year-over-year; for FY2025, it came in at $284.81 million, down 8.2% from FY2024.
- Research & Development has now declined for three consecutive years, though with a five-year compound annual growth rate of 5.2% (FY2020 to FY2025).
- In earlier years, Research & Development was $310.24 million in FY2024 (-19.9%), $387.33 million in FY2023 (-16.1%), $461.65 million in FY2022 (+35.6%) and $340.57 million in FY2021 (+53.8%).
- Quarterly Research & Development has moved between $58.9 million (Q3 2025) and $123.22 million (Q2 2022) over five years.
- Compared with a year earlier, Research & Development was higher in 1 of the last eight quarters, with an average decline of 9.1%.
- The best year-over-year quarter for Research & Development over five years was Q4 2021 (growth of 180.1%); the worst was Q3 2025 (a decline of 28.3%).
- Per Business Quant data, CRSP's Research & Development in the three quarters before Q2 2026 was $68.57 million (Q1 2026), $83.53 million (Q4 2025) and $58.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 67.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.15 Mn |
| Mar 31, 2026 | 68.57 Mn |
| Dec 31, 2025 | 83.53 Mn |
| Sep 30, 2025 | 58.90 Mn |
| Jun 30, 2025 | 69.89 Mn |
| Mar 31, 2025 | 72.48 Mn |
| Dec 31, 2024 | 71.74 Mn |
| Sep 30, 2024 | 82.16 Mn |
| Jun 30, 2024 | 80.17 Mn |
| Mar 31, 2024 | 76.17 Mn |
| Dec 31, 2023 | 95.14 Mn |
| Sep 30, 2023 | 90.70 Mn |
| Jun 30, 2023 | 101.56 Mn |
| Mar 31, 2023 | 99.94 Mn |
| Dec 31, 2022 | 103.56 Mn |
| Sep 30, 2022 | 116.62 Mn |
| Jun 30, 2022 | 123.22 Mn |
| Mar 31, 2022 | 118.25 Mn |
| Dec 31, 2021 | 103.10 Mn |
| Sep 30, 2021 | 83.50 Mn |
API Access
CRISPR Therapeutics AG Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();